Gap Fund: Single-step Support for Medical Product Development (UK)

The UK Research and Innovation (UKRI) MRC Gap Fund provides single-step funding for projects developing new or repurposed medicines, medical devices, diagnostics, or other medical interventions. Grants target projects addressing critical gaps in disease prevention, diagnosis, treatment, and monitoring, helping researchers generate essential preliminary data for further development.

Overview

The MRC Gap Fund supports single-step research projects that focus on one core goal, enabling rapid progression in medical innovation. It is ideal for initiatives aiming to:

• Advance precision prevention

• Enable early and accurate diagnosis

• Develop novel therapeutic approaches

• Improve outcome monitoring

• Enhance disease management through innovative technologies

Projects can address all human diseases and medical interventions, both within the UK and internationally.

Funding Details

• Total budget: £3,000,000

• Project funding range: £50,000–£300,000 (Full Economic Cost)

• Support is focused on a single critical goal rather than multiple stages.

• Funding may cover personnel, consumables, equipment, and other resources necessary to achieve the project objective.

Eligibility

• UK-based researchers, including early-career and established investigators

• Researchers at international institutions may apply under certain exceptions

• Specific units eligible: MRC Unit The Gambia and MRC/UVRI Uganda Research Unit at LSHTM

• Applicants must demonstrate active engagement in the project and capacity to generate preliminary data

Host Institution Requirements

• Institutions must commit to extending contracts for project staff if funding is awarded

• Provide mentorship and career development support for early-career researchers

Application Requirements

Applications must include:

1. Core Concept: Clearly outline the scientific idea and significance

2. Key Gap: Define the specific gap in medical research that the project addresses

3. Project Plan: Explain the methodology to achieve the single-step objective

4. Challenges & Risks: Identify potential hurdles and strategies to mitigate them

5. Preliminary Data: Evidence supporting the feasibility and rationale of the project

Why It Matters

• Bridges critical gaps in translational medical research

• Accelerates development of new medicines, diagnostics, and therapies

• Generates essential preliminary data needed for larger-scale research or clinical trials

• Supports early-career researchers and strengthens UK-based medical research capacity

Tips for Applicants

• Focus the project on one critical step rather than multiple stages

• Justify any request above the standard funding range with scientific rationale

• Provide strong preliminary data to demonstrate feasibility

• Ensure clear articulation of project significance and potential impact

• Confirm host institution support and resources before submission

FAQ

1. Who can apply? – UK-based researchers, including early-career investigators; exceptions apply for certain international units.

2. What types of projects are eligible? – Projects developing or repurposing medicines, medical devices, diagnostics, or other medical interventions targeting human diseases.

3. How much funding is available? – £50,000–£300,000 per project; total fund: £3,000,000.

4. Can preliminary or exploratory studies apply? – Yes, provided sufficient preliminary data exists to support the proposed single-step goal.

5. Are multi-stage projects eligible? – No, the fund is intended for single-step projects addressing a critical gap.

6. Are international researchers eligible? – Only specific units such as MRC Unit The Gambia and MRC/UVRI Uganda Research Unit are eligible.

7. What does host institution support involve? – Contract extensions, mentorship, career development, and resource provision.

Conclusion

The MRC Gap Fund offers a strategic opportunity to accelerate medical innovation by funding single-step projects that address critical gaps in healthcare research. By supporting targeted, high-impact initiatives, the fund enables researchers to generate essential data that can inform further development of novel medicines, devices, diagnostics, and interventions, strengthening the UK’s medical research ecosystem.